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X-linked mental retardation (XLMR) is an inherited
disorder that mostly affects males and is caused by
mutations in genes located on the X chromosome.
Here, we show that the XLMR protein PHF8 and
a C. elegans homolog F29B9.2 catalyze demethyla-
tion of di- and monomethylated lysine 9 of histone
H3 (H3K9me2/me1). The PHD domain of PHF8 binds
to H3K4me3 and colocalizes with H3K4me3 at tran-
scription initiation sites. Furthermore, PHF8 interacts
with another XMLR protein, ZNF711, which binds to
a subset of PHF8 target genes, including the XLMR
gene JARID1C. Of interest, the C. elegans PHF8
homolog is highly expressed in neurons, and mutant
animals show impaired locomotion. Taken together,
our results functionally link the XLMR gene PHF8 to
two other XLMR genes, ZNF711 and JARID1C, indi-
cating that MR genes may be functionally linked
in pathways, causing the complex phenotypes
observed in patients developing MR.
INTRODUCTION
Individuals affected by mental retardation are characterized
by impairment of intellectual functioning and deficits in adaptive
behavior (American Psychiatric Association, 1994; Vaillend et al.,
2008). X-linked mental retardation (XLMR) is an inherited dis-
order mostly affecting males and is often characterized by a
complex phenotype. The XLMR conditions are grouped in two
categories: a nonsyndromic form, in which mental retardation
(MR) is the only clinical manifestation, and the syndromic form,
in which MR is associated with a wide range of anomalies invarious combinations, including biochemical disorders, neuro-
logical symptoms, skeletal abnormalities, and facial dysmor-
phies (Chiurazzi et al., 2008; Inlow and Restifo, 2004). XLMR is
a genetic abnormality of the X chromosome caused by deletions,
duplications, or inversions of large gene regions. However,
monogenic mutations of the X chromosome are also a common
cause of XLMR. XLMR genes are distributed over the entire
X chromosome, and until now, around 82 XLMR genes have
been identified and cloned. The XLMR gene products can be
found in all cellular compartments and are involved in basic bio-
logical functions such as metabolism, DNA/RNA processing,
protein synthesis, and cell-cycle regulation. However, a major
part of the genes is involved in signal transduction and transcrip-
tional regulation.
The transcriptional regulatory factors consist of both putative
DNA sequence-specific binding factors—among these, a num-
ber of zinc finger proteins, including ZNF41, ZNF81, ZNF674,
and ZNF711 (Chiurazzi et al., 2008; Kleefstra et al., 2004; Lugten-
berg et al., 2006; Shoichet et al., 2003; Tarpey et al., 2009)—and
a variety of transcriptional cofactors modulating chromatin
structure. For the latter, two of the XLMR proteins, JARID1C
and PHF8 (Iwase et al., 2007; Jensen et al., 2005; Laumonnier
et al., 2005; Tahiliani et al., 2007), belong to the JmjC group of
proteins. This protein family has 27 members, and several of
these have recently been shown to be histone lysine demethy-
lases playing important roles in development and differentiation
(Cloos et al., 2008; Klose and Zhang, 2007; Lan et al., 2008).
Based on alignments of the JmjC domain, the family can be
divided into 11 subgroups. Seven of these groups have been
shown to catalyze the demethylation of methylated forms of
lysines and arginines on histones H3 and H4 (H3K4, H3K9,
H3K27, H3K36, and H3 R2/H4 R3). Mutations of JARID1C cause
syndromic XLMR (Jensen et al., 2005), manifested by micro-
cephaly and mild dysmorphic features. JARID1C belongs to
the JARID1 subgroup, which has intrinsic H3K4me3/me2 deme-
thylase activity (Cloos et al., 2008). JARID1C interacts with theMolecular Cell 38, 165–178, April 23, 2010 ª2010 Elsevier Inc. 165
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Figure 1. PHF8 Demethylates H3K9me2
In Vivo
(A) Phylogenetic analysis and schematic represen-
tation of the human PHF family. Alignment of the
proteins and construction of the phylogenetic
tree were conducted using the ClustalW (http://
align.genome.jp). Shown are jumonji C domain
(JmjC) and plant homeotic domain (PHD).
(B–E) (B) 293 cells were transfected with HA-
tagged PHF8, (C) a PHF JmjC mutant, (D)
a naturally occurring XLMR mutant with mutation
in the JmjC domain (F279S), and (E) a C-terminal
deletion (K177X) found in XLMR patients.
The transfected cells were fixed, costained for
the indicated histone modification and for the
expression of the proteins (anti-HA), and analyzed
by confocal microscopy. White arrows indicate
cells expressing the tested protein. The cells
were counterstained with DAPI to visualize cell
nuclei.
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PHF8 and ZNF711 Cooperate in Neural FunctionCo-REST complex and is involved in the regulation of certain
neuronal genes (Tahiliani et al., 2007). The PHF8 gene is located
at Xp11.22. The enzymatic and gene regulatory function of
PHF8 is at the present unknown. Both deletions and point muta-
tions in the JmjC domain of PHF8 have been reported and are
associated with a syndromic phenotype characterized by mild
XLMR and cleft lip/palate (Abidi et al., 2007; Koivisto et al.,
2007; Laumonnier et al., 2005). Based on the overall domain166 Molecular Cell 38, 165–178, April 23, 2010 ª2010 Elsevier Inc.structure and sequence homology, PHF8
is a potential demethylase related to
KIAA1718 and PHF2, a JmjC subfamily
with no assigned enzymatic specificity
(Figure 1A). Two closely related homo-
logs are present in C. elegans showing
conservation of the overall domain struc-
ture and of the primary amino acid
sequence in the PHD and JmjC domains,
indicating an evolutionary conserved role
for these proteins (Figure S1A available
online). Here, we show that PHF8 is
an H3K9me2/me1 demethylase, which
binds H3K4me3 through its PHD domain
and localizes to the H3K4me3-positive
region of transcriptionally active genes
in vivo, including a number of XLMR
genes. PHF8 interacts directly with
another XLMR protein, ZNF711, and
co-occupies the promoter region of
common target genes, suggesting a
role for this factor in the recruitment
of PHF8. A C. elegans homolog of
PHF8 exhibits intrinsic H3K9me2 and
H3K27me2 demethylase activities and is
strongly expressed in neurons and is
required for normal locomotion. Mutation
of this gene causes a global increase in
H3K9me2 and H3K27me2 levels duringdevelopment, specifically linking the enzymatic activity to
histone methylation in vivo.
RESULTS
PHF8 Is an H3K9me2/me1 Demethylase
To examine the catalytic activity of PHF8, we transfected an
HA-tagged version of PHF8 into HEK293 cells and analyzed
Molecular Cell
PHF8 and ZNF711 Cooperate in Neural Functionhistone methylation by immunofluorescence. As shown in
Figure 1B, ectopic expression of PHF8 led to a slight decrease
in dimethylated H3K9 levels, whereas the H3K9me1 and
H3K9me3 levels were not significantly affected. The quantifica-
tion of the H3K9me2 results showed that the observed decrease
is significant and that ectopic expression of an XLMR-associ-
ated mutant of PHF8 led to a slight increase in H3K9me2 levels
(Figure S1B). Also, no significant changes were observed for
global H3K4me2, H3K4me3, and H3K27me2 methylation (Fig-
ure S1C). To test for the specificity of the reduction in H3K9
levels, we generated a PHF8 mutant (H247G/I248S/D249G), in
which two of the three amino acids in the JmjC domain that is
believed to be involved in Fe(II) binding were mutated. When
this mutant was ectopically expressed in HEK293 cells, no
reduction in H3K9 methylation levels was observed. Moreover,
we tested the activity of two XLMR-associated PHF8 mutant
proteins: F279S, carrying a mutation in the JmjC domain (Koi-
visto et al., 2007) and a C-terminal truncated mutant (K177X)
deleting the nuclear localization signal (Abidi et al., 2007). Both
of these mutants were found to have lost the ability to demethy-
late H3K9me2, probably by the inactivation of the intrinsic enzy-
matic activity and, for the latter, delocalization of the protein to
the cytoplasm (Figures 1C–1E). Taken together, these data
suggest that the PHF8 is an H3K9me2 demethylase and that
the loss of this activity is associated with the development of
XLMR.
To determine the intrinsic enzymatic specificity of PHF8, we
affinity purified full-length recombinant his-tagged PHF8 from
insect cells and tested its activity in vitro (Figure 2A). Incubation
of purified calf thymus histones with increasing amounts of
recombinant purified PHF8 (Figure 2B) led to a progressive
loss of H3K9me2 methylation, whereas no detectable decrease
in H3K9me1 and H3K9me3 levels was observed. In these
assays, we did not observe any reduction in H3K27 methylation,
despite the conservation of the four amino acids (ARKS) sur-
rounding the methylated lysine of H3K9 and H3K27. Moreover,
no changes of methylation were detected for methylated H3K4,
H3K36, and H4K20, suggesting that the preferred substrate for
PHF8 is H3K9me2. No enzymatic activity for PHF8 was detected
when a histidine involved in iron binding located in the JmjC
domain was changed to arginine (H247R) (Figures 2C and
S2A), confirming the intrinsic enzymatic activity of PHF8. More-
over, we were not able to detect demethylation of nucleosomes
as it has been observed before for other published histone
demethylases (Iwase et al., 2007; Klose et al., 2006; Whetstine
et al., 2006), suggesting that this is a poor substrate under stan-
dard assay conditions (Figure S2B). However, the accurate
determination of histone demethylase specificity using histones
as substrate can be limited due to the unknown quantitative
differences between the different methylation states of the
histones and antibody specificity.
Thus, to further characterize the enzymatic specificity of
PHF8, we incubated increasing amounts of purified PHF8 with
equimolar amounts of 40-mer peptides covering the histone
H3 amino-terminal tail with the relevant methylation levels at
K9(me3/me2/me1) and K27me2 position, respectively (Fig-
ure 2D). The reaction products were analyzed by mass spec-
trometry. In agreement with the specificity observed for histones,the H3K9me2 peptide was converted to the monomethylated
and, to a lesser degree, the unmethylated form. Accordingly,
the H3K9me1 peptide was also converted to the unmethylated
peptide, albeit with less efficiency when compared to the
H3K9me2 peptide. We did not observe any detectable demethy-
lation of the H3K9me3 and the H3K27me2 peptides. However,
at high concentrations of PHF8 catalyzing complete demethyla-
tion of the H3K9me2 peptide to its unmethylated form, we
detected a low percentage conversion of the H3K27me2 peptide
to the monomethylated form (Figure S2C). Collectively, these
results indicate that the enzymatic specificity and order of
substrate preference for PHF8 is H3K9me2 > H3K9me1 and
that PHF8 only at very high concentrations has the ability to
demethylate H3K27me2 in vitro.
The PHF8 PHD Finger Binds to H3K4me3/me2
A common feature of the PHF family is the presence of amino-
terminally localized PHD fingers. Recent studies have demon-
strated that a subset of PHD fingers binds to histone tails and
that the affinity is regulated by posttranslation modifications of
the histone tails (Champagne and Kutateladze, 2009; Chan
et al., 2009; Wysocka et al., 2006). These interactions are
functionally important for regulating transcription. To examine
whether the PHD finger of PHF8 binds to histone tails, we puri-
fied the PHF8 PHD domain as a GST fusion protein. The GST-
PHD fusion was analyzed for binding to a peptide array covering
large parts of H2A, H2B, H3, H2AX, and H4 modified by different
degrees and combinations of methylation, acetylation, and
phosphorylation (Figure 2E). The analysis demonstrated that
the PHD domain binds directly to H3K4me3 and, to a lesser
extent, H3K4me2. Of interest, the interaction was also observed
when peptides, in addition to the H3K4me3, were modified by
acetylation at the H3K9/K14 positions, modifications normally
associated with transcriptionally active genes. Although we
have not performed further experiments to validate the finding,
we noted that the PHD domain of PHF8 was also able to bind
to a peptide of H3 containing amino acids 44–64.
To examine the binding specificity further in the context of
both the PHD and JmjC domain, a GST fusion protein encom-
passing the PHD and JmjC domain was incubated with biotiny-
lated histone H3 peptides tri- or dimethylated at either the K4 or
K9 positions (Figure 2F). Whereas no binding to peptides meth-
ylated at the K9 position was detected, a strong binding to
H3K4me3 was observed, supporting the peptide array mapping
data. Finally, endogenous PHF8 expressed in HeLa was shown
to bind H3K4me3, whereas no binding was detected for the
unmodified or H3K9me3/me2-containing peptides (Figures 2G
and S2D). Together, these data demonstrate that the PHD finger
of PHF8 can bind directly to H3K4me3-modified histone tails and
that the JmjC domain, at least under the binding conditions, does
not interfere with H3K4me3 or mediate stable binding to its
substrate H3K9me2.
PHF8 and H3K4me3 Colocalize at Target Genes
Genome-wide analysis of H3K4me3 has revealed that this chro-
matin modification is preferentially associated with transcription
start sites (TSS) (Barski et al., 2007). The affinity of PHF8 for
H3K4me3 could suggest that PHF8 will bind target genes aroundMolecular Cell 38, 165–178, April 23, 2010 ª2010 Elsevier Inc. 167
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PHF8 and ZNF711 Cooperate in Neural Functionthe TSS positive for H3K4me3. To determine the genome-wide
binding sites of PHF8, we performed genome-wide location
analysis of PHF8 in human neuroblastoma SH-SY5Y cells by
high-resolution ChIP-seq (chromatin immunoprecipitation fol-
lowed by DNA sequencing) analysis using antibodies specific
for PHF8 and correlated this with the binding pattern of RNA
polymerase II (RNA pol II) and H3K4me3. The total number of
peaks detected for PHF8 based on 9.8 million sequence reads
and 9.1 million reads for H3K4me3 after IgG normalization
were 17075 and 19534, respectively. Annotation of the peaks
to genes using the hg18 genome database revealed that
10039 genes were positive for H3K4me3 and 7682 genes were
bound by PHF8 within ± 1000 bp of the TSS. The Venn diagram
in Figure 3A illustrates the number of genes positive for PHF8 and
H3K4me4 and demonstrates a major overlap of PHF8- and
H3K4me3-positive genes (82%), whereas 35% of H3K4me3-
positive genes are PHF8 negative. In general, PHF8 either coloc-
alizes or partly overlaps with the regions positive for H3K4me3
and covers the putative TSS of the target genes. Analysis of
the distance correlation between the peaks detected for PHF8
and H3K4me3 and transcriptional start sites demonstrates that
both peaks are predominantly overlapping with the TSSs con-
taining a common peak maximum at around +200 (Figure 3B).
Furthermore, 82% of the nucleotides bound by H3K4me3 are
also bound by PHF8 (Figure 3C). However, there is no strict
correlation between PHF8 binding and H3K4me3 levels (com-
pare, for instance, CXXC1 and MBD1; Figure S3A). Of interest,
35% of the H3K4me3-positive genes are negative for PHF8,
indicating that other factors in addition to the PHD domain of
PHF8 might determine gene targeting. A major part of PHF8-
bound genes (69%) is also RNA pol II positive, suggesting
that they are either ‘‘poised’’ for transcription or are transcrip-
tionally active. Because we observed a slight decrease in the
binding of the PHD domain of PHF8, an H3K4me3 peptide con-
taining K9Ac and K14Ac compared to H3K4me3 alone (Fig-
ure 2E), we speculated that histone hyperacetylation could
influence the recruitment of PHF8 to target gene promoters.
However, ChIP experiments using antibodies specific for
H3K9ac, H3K14ac, and H3K4me3 showed that PHF8 is associ-
ated with genes that are positive for all three histone marks
(Figure S3B). This result suggests that hyperacetylation of his-
tones is not influencing the binding of PHF8 to target genesFigure 2. PHF8 Demethylates H3K9me2/me1 In Vitro and Binds to H3K
(A) SDS-PAGE analysis of purified His-tagged recombinant PHF8 expressed in in
SDS-PAGE and stained using Coomassie blue. The arrow indicates the position
(B) Demethylation assays of histones incubated with 1.5, 4.5, and 12.5 mg of recom
assays. The middle panels show the reactions probed with the indicated antibod
(C) Demethylation assays of histones incubated with 1.5, 4.5, and 12.5 mg of reco
stain of the histones present in the assays. The middle panels show the reaction
(D) H3K9me3/me2/me1 and H3K27me2 peptides (2.5 mg) were incubated with or
A shift in mass equivalent to one methyl group is indicated as ‘‘Me.’’
(E) Peptide array spotted with six replicates of modified peptides covering the lar
and combinations of methylation, acetylation, and phosphorylation. The modifica
harboring the PHD finger of PHF8, and the detection of bound protein was perfo
(F) In vitro binding experiment. A purified GST-PHF8 fusion protein (amino acids
histone H3 peptides methylated at either the K4 or K9 position. After precipitat
immunoblotting.
(G) In vitro binding experiments. A lysate from HeLa cells was incubated with
After precipitation with Streptavidin-agarose, bound PHF8 was detected by SDSand further supports the notion that PHF8 target genes are tran-
scriptionally active.
Because mutation of PHF8 causes mental retardation, PHF8
might potentially be involved in the regulation of other XLMR
genes. In SH-SY5Y cells, PHF8 bound a number of reported
XLMR genes. Inspection of selected XMLR genes JARID1C,
ZNF41, and ZNF81 supported the localization of PHF8 at the
H3K4me3-positive region surrounding the TSS site (Figure 3D).
These targets were validated by qChIP (ChIP followed by real-
time quantitative PCR), showing the binding of PHF8 and
H3K4me3 (Figure 3E). These genes were also positive for RNA
pol II, indicating active transcription (Figure 3D). Whereas the
chromatin status in terms of methylation is unknown for these
genes when inactive, all genes were negative for H3K9me2, sug-
gesting a potential role for PHF8 in the elimination of this repres-
sive chromatin mark. The colocalization of PHF8 and H3K4me3
indicates a role for PHF8 as a positive regulator of transcription
by locally reducing H3K9me2 at the TSS. Unfortunately, the
current available antibodies specific for H3K9me2 are not very
potent in ChIP assays, and therefore, they do not work reliably
in genome-wide location studies (unpublished observations;
Barski et al., 2007). To test that the H3K9me2 antibodies can
work in ChIP, we showed that H3K9me2 is enriched at the syn-
aptophysin gene (SYP), which has earlier been reported to be
H3K9me2 positive in SH-SY5Y cells (Ekici et al., 2008), and,
importantly, it is not bound by PHF8. This result indicates that
the lack of H3K9me2 at PHF8 target genes is due to the absence
of the mark.
PHF8 Binds to the XLMR Gene Product ZNF711
The lack of PHF8 binding to all H3K4me3-positive genes and
differential binding to H3K4me3-positive binding indicates that
other factors influence PHF8 recruitment. To identify such
recruiters/cofactors, we purified PHF8-interacting proteins by
tandem affinity chromatography. Flag-HA-tagged PHF8 was
stably expressed in human TREX 293 cells, and interacting
proteins were purified from nuclear extracts by Flag- followed
by HA-affinity chromatography (Figure 4A). Subsequently, inter-
acting proteins were identified by mass spectrometry. A single
protein, ZNF711, was specifically highly enriched in the affinity
purification of PHF8-associated proteins. The ZNF711 gene is
located at Xq21.1-q21.2 and encodes a zinc finger protein with4me3
sect cells. Marker is a molecular weight standard. Samples were subjected to
of recombinant PHF8 (120 kDa).
binant PHF8; bottom panels show Ponceau stain of the histones present in the
ies and assayed by immunoblotting.
mbinant PHF8 or a PHF8 JmjC mutant (H247R); bottom panels show Ponceau
s probed with the indicated antibodies and assayed by immunoblotting.
without recombinant PHF8 (0.5 or 1.5 mg) and analyzed by mass spectrometry.
ge parts of histone H2A, H2B, H3, H2AX, and H4 modified by different degrees
tions are listed in the panel. The array was incubated with a GST fusion protein
rmed as described in the Supplemental Experimental Procedures.
1–548) containing the PHD and JmjC domain was incubated with biotinylated
ion with Streptavidin-agarose, bound PHF8 was detected by SDS-PAGE and
biotinylated histone H3 peptides methylated at either the K4 or K9 position.
-PAGE and immunoblotting.
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Figure 3. PHF8 Binds Target Genes in the H3K4me3-Positive Region Surrounding the TSS
(A) Venn diagram showing the overlap and number of genes positive for PHF8, H3K4me3, and RNA pol II in human neuroblastoma SH-SY5Y cells.
(B) Distribution of the distance between PHF8 (light blue) and H3K4me2 (dark blue) peaks and the transcription start sites (TSS).
(C) PHF8 nucleotides that are also bound by H3K4me3.
(D) Binding profiles of the XLMR genes JARID1C, ZNF41, and ZNF81 for PHF8, H3K4me3, and RNA pol II obtained from ChIP-seq analysis; the chromosomal
locations are indicated in the top of the panel according to hg18. The Y axes indicate the number of sequenced reads.
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followed by 12 consecutive Zn-C2H2 domains potentially
involved in transcriptional activation and sequence-specific
DNA binding, respectively (Figure 4B). The gene is predomi-
nantly expressed in parts of the brain and retina in mice (Fig-
ure S4B). In humans, the gene is expressed in neural tissues
and highly expressed in 293 cells and in neuroblastoma SH-
SY5Y cells (Figure S4A). These cell lines also express high levels
of PHF8 (Figures S4C and S4D). Recently, a mutation of the zinc
finger region of ZNF711 was shown to be associated with mild
mental retardation in patients resembling the MR phenotype
observed for mutations of PHF8 (Tarpey et al., 2009). However,
the cleft lip/palate phenotype associated with PHF8 mutations
was not observed in these patients.
To verify the PHF8-ZNF711 interaction, we coexpressed
HA- and Myc-tagged versions of PHF8 and ZNF711 and ana-
lyzed complex formation by coimmunoprecipitation. As shown
in Figure 4C, immunoprecipitation of either HA-PHF8 or Myc-
ZNF711 highly enriches the other factor, confirming the interac-
tion. Consistent with this finding, endogenous ZNF711 was also
immunoprecipitated from HEK293 cells by an anti-PHF8, and
endogenous PHF8 was immunoprecipitated using an anti-
ZNF711 antibody (Figure 4D). These results demonstrate that
ZNF711 binds to PHF8 in vivo. Furthermore, a functional interac-
tion between the two proteins was observed in a mammalian
two-hybrid assay (Figure 4E). The strong interaction in these
assays indicates that PHF8 and ZNF711 bind directly to each
other and that ZNF711 could be a PHF8 recruiter/cofactor.
To investigate whether ZNF711 influenced the enzymatic activ-
ity of PHF8 in vitro, we purified recombinant ZNF711 (Fig-
ure S4E) and titrated equimolar amounts of PHF8 into the his-
tone demethylation assay. When compared to PHF8 alone, the
inclusion of ZNF711 in the assay resulted in a slight increase in
demethylation activity (Figure 4F). Whereas the interpretation
of the assay is complex, partly due to the instability of purified
PHF8 and the subtle effect of ZNF711, the results suggest
that a ZNF711-PHF8 complex is active in vivo. In line with the
lack of PHF8 activity on nucleosomes, PHF8 together with
ZNF711 did not catalyze demethylation of nucleosomes in vitro
(Figure S4F).
ZNF711 Colocalizes with PHF8 on a Subset of PHF8
Target Genes
To examine the role of the interaction between PHF8 and
ZNF711 in gene regulation, we generated a specific antibody
against ZNF711, and, based on 9.6 million sequence reads,
a genome-wide map of ZNF711 DNA-binding sites in SH-SY5Y
cells was obtained by ChIP-seq analysis. The 1875 binding
peaks were detected, and annotation of the peaks to genes
within 1 kb of the TSS using the hg18 genome database revealed
that 1204 of the peaks mapped to 1103 genes positive for
ZNF711. The overlap between ZNF711- and PHF8-bound genes
were80%, and the majority (97%) was H3K4me3 positive, as
shown in the Venn diagram in Figure 5A. Similar to PHF8,(E) qChIP analysis of the XMLR genes JARID1C, ZNF41, and ZNF81 in SH-SY5Y
The enrichment of the ChIP assays is shown as percentage of input. qChIP a
PHF8, H3K4me3, H3K9me2, and IgG (control) was used as positive control for HZNF711 bound its target genes in close vicinity of the TSS.
Furthermore, genes strongly binding ZNF711 also bound high
levels of PHF8, and the proteins showed overlapping or closely
juxtaposed binding regions (Figure 5B). These results further
support the finding that the two proteins interact. In contrast to
PHF8, which binds to a number of XLMR genes in SH-SY5Y
cells, ZNF711 only bound JARID1C. To validate the ChIP-seq
mapping of ZNF711 and determine chromatin modifications,
we analyzed the binding of ZNF711, PHF8, and the chromatin
status for H3K4me3 and H3K9me2 for JARID1C and two highly
scoring ZNF711 targets C2orf34 and PCBP2 by qChIP using
primer sets covering the ZNF711 binding region (Figure 5C).
The genes showed high enrichment for ZNF711, PHF8, and
H3K4me3, whereas H3K9me2 methylation was not detected,
indicating a role for PHF8 in the removal of this mark at TSS.
To understand whether ZNF711 is involved in the recruitment
of PHF8 to target genes, we downregulated ZNF711 expression
in 293 cells using shRNA and analyzed ZNF711 and PHF8
binding to JARID1C and C2orf34. As expected, the binding of
both ZNF711 and PHF8 was reduced. In addition, the levels of
H3K4me3 were reduced, further supporting a role for the com-
plex in active transcription. An increase in H3K9me2 levels
upon decreased binding of PHF8 to the analyzed gene loci
was not observed. Moreover, analysis of H3K9me2 levels asso-
ciated with JARID1C and C2ORF34 500 bp downstream and
1000 kb upstream of the transcription start site did not show a
significant increase in H3K9me2 levels after knockdown of PHF8
(Figure S5A). As shown below, the PHF8 homolog in C. elegans
F29B9.2 demethylates both H3K9me2 and H3K27me2, and we
therefore tested whether knockdown of PHF8 could affect
H3K27me2 levels at target genes even though PHF8 did not
show activity toward this mark in in vitro and in vivo assays.
H3K27me2 ChIP experiments did not lead to any detectable
increase in H3K27me2 levels at the transcription start sites of
JARID1C and C2ORF34 upon knockdown of PHF8 (Figure S5B).
To test whether redundancy with the other two related PHF8
homologs PHF2 and KIAA1718 might explain the lack of
a change in H3K9me2 levels at target gene promoters, RNAi
experiments against all three genes were performed. We did
not observe any effect on H3K9me2 levels after single or com-
bined downregulation of PHF8, PHF2, and KIAA1718 expression
levels on the PHF8 target genes JARID1C and C2ORF34 (Fig-
ures S5C and S5D).
To test whether the downregulation of ZNF711 and PHF8
would lead to a change in transcription of target genes, we
tested the expression of nine different ZNF711/PHF8 target
genes by qPCR following shRNA-mediated knockdown of
ZNF711 and PHF8 expression. As shown in Figure 5E, the
expression of all of the tested target genes was significantly
decreased in 293 cells expressing shRNAs to ZNF711 or PHF8
(Figure 5E). A similar decrease in expression levels of ZNF711-
PHF8 target genes was also observed in SH-SY5Y cells fol-
lowing siRNA-mediated inhibition of PHF8 expression (Fig-
ure S5F). In contrast, we did not observe any effect of inhibitioncells using antibodies against PHF8, H3K4me3, H3K9me2, and IgG control.
nalysis of the gene coding for synaptophysin (SYP) using antibodies against
3K9me2. Error bars represent SD; n = 3.
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(Figure S5E).A PHF8 Homolog in C. elegans Has H3K9/27me2
Demethylase Activity and Modulates Coordinate
Locomotion
C. elegans has two closely related sequences, F29B9.2 and
F43G6.6, that have strong homology to the human PHF family
(Figure S1). To identify the in vivo role of this class of demethy-
lases, we characterized the function of F29B9.2 (Figure 6A).
Similarly to the human counterpart, recombinant full-length
F29B9.2 (cePHF8) demethylates H3K9me2 in vitro (Figure 6B).
We also noticed that H3K27me2 was reduced in these con-
ditions, suggesting that F29B9.2 may have a dual specificity
not identified in the human PHF8. To investigate the role
of F29B9.2 in vivo, we analyzed a mutant allele of F29B9.2,
tm3713, generated by the Japanese National BioResource
Project. The tm3713 allele carries a deletion of 575 bp spanning
the fourth and fifth exon of F29B9.2 (Figure 6A), and the
predicted protein, if produced, would therefore lack the PHD
domain. In agreement with the results obtained in vitro, protein
lysates from mutant animals showed an increase in global levels
of H3K9me2 and H3K27me2, compared to wild-type animals
(Figure 6C). Furthermore, inhibition of F29B9.2 expression
by RNA interference also led to an increase in H3K9me2 and
H3K27me2 levels. These results strongly suggest that F29B9.2
is an H3K9me2 and H3K27me2 demethylase.
To obtain information regarding the functional role of F29B9.2
in C. elegans, we analyzed the expression pattern of F29B9.2 by
generating a translational fusion between the F29B9.2 genetic
locus and GFP. Transgenic animals bearing F29B9.2::GFP in
an extrachromosomal array exhibited strong nuclear fluores-
cence in neurons (Figure 6D), even though a few other cells
(some muscle, intestinal, and hypodermal cells) showed a faint
fluorescence. The neuronal expression pattern together with
the fact that human PHF8 is a XLMR gene prompted us to test
the deletion allele tm3713 for phenotypes related to the function
of the nerve system. Of interest, the tm3713 allele exhibited
defects in body movement. Wild-type N2 animals moved by
alternating dorsal and ventral flexions along the body length,
producing a regular sinusoidal track on bacteria (Figure 6E).
In contrast to this, the track pattern left by tm3713 was irregular,
with increased wavelength (distance between successive peaks
of a wave) but unchanged amplitude of the wave. This phenotype
is not due to increased length of the animal body compared
to wild-type (data not shown). Strikingly, reintroduction of(C) Coimmunoprecipitation of PHF8 and ZNF711. Phoenix cells were transfected o
ZNF711 and were immunoprecipitated using antibodies against the HA-tag or My
western blotting using antibodies against the Myc-tag or HA-tag.
(D) Coimmunoprecipitation of endogenous PHF8 and ZNF711. HEK293 cells wer
and PHF8. The precipitates were analyzed by SDS-PAGE followed by western b
(E) Interaction of PHF8 and ZNF711 in a mammalian two-hybrid assay. U2OS cell
gene driven by the adenovirus E1B minimal promoter (TATA) fused to five upstream
in the bottom of the panel. For correction of transfection efficiency, pCMV-lacZ w
sidase activity. All experiments were performed in triplicate and reproduced at le
(F) Demethylation assays of histones incubated with 1.5, 4.5, and 12.5 mg of rec
ZNF711; bottom panels show Ponceau stain of the histones present in the assay
and assayed by immunoblotting.F29B9.2 gene in tm3713 background (tm3713R) restored the
wild-type phenotype, demonstrating that the locomotion defect
is specific to the loss of F29B9.2. Moreover, re-expression of the
gene in mutant background under a pan-neuronal promoter (rab-
3) (Nonet et al., 1997), but not under a muscle promoter (myo-3)
(Fire and Waterston, 1989), rescued the phenotype associated
with loss of F29B9.2 (Figure 6F). We did not observe other
phenotypes related to neuronal function, such as pumping,
dye filling in sensory neurons, egg laying, sensitivity to levami-
sole, aldicarb, and serotonin in the tm3713 mutant allele (data
not shown). However, in conclusion, our data suggest that
F29B9.2 is important for normal neuronal function in C. elegans.DISCUSSION
More than 82 genes have been linked to XLMR, and this number
is expected to increase in the coming years (Chiurazzi et al.,
2008). XLMR is believed to affect 1 in 600 in the male population;
however, despite the high prevalence, the complexity of the
disease and the large number of genes associated with it have
hampered a better understanding of the molecular mechanisms
leading to mental retardation. In this report, we have linked three
previously mapped XLMR genes (Figure 6F), two of them
uncharacterized, which are believed to have a causative role in
XLMR (Abidi et al., 2007; Koivisto et al., 2007; Laumonnier
et al., 2005; Tarpey et al., 2009). We have demonstrated that
PHF8 is an H3K9me2/me1 demethylase and that it is bound
very close to transcriptional start sites of a large number of active
or poised genes. Of interest, the large majority of PHF8-bound
genes are also associated with H3K4me3, and the PHF8 and
H3K4me3 binding profiles are strikingly similar. These results
suggest that the H3K4me3 mark could be involved in the recruit-
ment of PHF8 to active promoters, and accordingly, we show
that the PHD domain of PHF8 binds directly to H3K4me3.
However, the demonstration that PHF8 is not bound to all
H3K4me3-positive genes suggests that this mark is not sufficient
for PHF8 recruitment and that other factors are involved. In
agreement with this, we found that PHF8 directly interacts with
ZNF711, suggesting a role for this factor in the recruitment of
PHF8 to common promoters. Thus, the interaction between
ZNF711 and PHF8 may instead stabilize the association of
PHF8 with the histone tail either before or after H3K4me3 meth-
ylation and catalyze the efficient removal of H3K9me2.
Dimethylation of H3K9 has mainly been associated with tran-
scriptionally inactive genes (Peters et al., 2003) and may catalyze
gene repression by recruitment of repressive complexesr cotransfected with the expression vectors pCMV-HA-PHF8 and pCMV-Myc-
c-tag as indicated. The precipitates were analyzed by SDS-PAGE followed by
e lysed and immunoprecipitated with the indicated antibodies against ZNF711
lotting using antibodies against ZNF711 and PHF8.
s were transfected with a pGAL-Luc reporter plasmid containing the luciferase
GAL4-binding sites or cotransfected with the expression constructs indicated
as included in all assays, and luciferase activity was normalized to b-galacto-
ast three times. Error bars represent SD; n = 3.
ombinant PHF8 alone and/or in the presence of 1, 3, and 9 ug of recombinant
s. The middle panels show the reactions probed with the indicated antibodies
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PHF8 and ZNF711 Cooperate in Neural Functioninteracting with the H3K9 mark. Alternatively, H3K9me2 may
hinder acetylation of the H3K9 position, a histone modification
present at the TSS site of active genes. Consistent with a role
of PHF8 as an H3K9me2 demethylase, PHF8 is bound to active
genes lacking the H3K9me2 mark. Even though our results show
that both PHF8 and ZNF711 contribute to the activation of target
genes, including JARID1C, we have so far been unable to detect
an increase in H3K9me2 levels upon PHF8 or ZNF711 downre-
gulation. Whereas transcription factors other than ZNF711 and
PHF8 are probably important for transcription at target
promoters, this observation indicates that, in a static cellular
system like the SH-SY5Y cells, recruitment of a specific
H3K9me2 methyltransferase is not a default mechanism. Our
data showing that inactivation of a C. elegans PHF8 homolog
leads to a strong overall increase in H3K9me2 and H3K27me2
levels demonstrate the biochemical role of the demethylase
activity in vivo. However, from this study, it is not possible to
discriminate whether it is the increased H3K9me2 or
H3K27me2 levels or both leading to the observed phenotype in
C. elegans. Furthermore, although we do not have any evidence
for a role of PHF8 in demethylating other methylated lysines than
those present on H3K9 and H3K27, PHF8 and its C. elegans
homolog might catalyze demethylation of other methylated
lysines present on histones or other proteins in vivo.
It is striking to note that inactivation of PHF8 in humans and
its C. elegans homolog gives relatively mild phenotypes, taking
the large number of genes that are potentially regulated by
PHF8 into account. This suggests that the PHF8 demethylases
are not functioning as on-off switches for transcription but,
rather, appear to fine-tune transcription, and their function is
only important for the specific development of certain cell types.
Alternatively, due to a potential redundant function of the other
proteins of the PHF8 family and potential ZNF711 homologs,
PHF8 and ZNF711 might contribute to many other cellular
processes in addition to neural development. In support of
this, we have shown that the PHF8 and ZNF711 bind to a large
number of genes that are required for the proliferation and differ-
entiation of many different cell types in addition to neural cells.
In conclusion, we have demonstrated that PHF8 catalyzes the
demethylation of H3K9me2/me1 and that it associates with the
active or poised H3K4me3-positive and H3K9me2-negative
genes, including the XLMR gene JARID1C. Furthermore, our
results suggest a role for the transcription factor and XLMR
protein ZNF711 in the recruitment of PHF8 to a subset of target
genes, which may stratify those involved in mental retardation
from those involved in cleft/lip palate malformation. Finally,
the C. elegans homolog F29B9.2 of PHF8 is also an H3K9me2
demethylase, and consistent with this and the important role ofFigure 5. PHF8 Colocalizes with ZNF711 on Target Genes
(A) Venn diagram showing the overlap and number of genes positive for ZNF711
(B) Binding profiles of the ZNF711 target genes JARID1C, C2ORF34, and PCBP
locations are indicated in the top of the panel according to hg18. The Y axes ind
(C) qChIP analysis of ZNF711 target genes JARID1C,C2ORF34, andPCBP2 in SH
IgG control. The enrichment of the ChIP assays is shown as percentage bound o
(D) qChIP analysis of ZNF711 target genes JARID1C andC2ORF34 in HEK293 cell
PHF8, H3K4me3, and IgG control.
(E) Expression analysis of ZNF711-PHF8 target genes after shRNA-mediated ZN
Error bars represent SD; n = 3.PHF8 in neuronal function, inactivation of F29B9.2 leads to unco-
ordinated locomotion.
EXPERIMENTAL PROCEDURES
Cloning Procedures
The open reading frames (ORF) of human PHF8 and ZNF711 were generated
by PCR amplification using a human fetal brain cDNA library (Invitrogen)
as template. The ORF of C. elegans F29B9.2 (cePHF8) was amplified from
C. elegans cDNA. The amplified fragments were cloned into the pCR8/GW
gateway entry vector (Invitrogen, Carlsbad, CA), and the DNA sequences
were verified by sequencing. To generate expression vectors, the appropriate
entry clones were transferred into gateway-compatible pCMV-HA, pCMV-
Myc, baculovirus virus transfer vectors pVL-flag.his and pACGHlt-A, and
pGEX for E. coli expression. shRNA constructs targeting PHF8 and ZNF711,
shPHF8 (bp 1653–1671) were constructed in pFUGW-UbqC-HygroEGFP,
and shZNF711 in pLKO.1 was obtained from Sigma-Aldrich.
Generation of Antibodies to PHF8 and ZNF711
Polyclonal antibodies were generated by immunizing rabbits with affinity-
purified insect cell-produced GST-PHF8 (amino acids 1–548) or bacterially
expressed GST-ZNF711 (amino acids 1–358). The antibodies were absorbed
on GST-coupled cyanogen bromide-activated Sepharose (GE Healthcare) and
subsequently affinity purified using Sepharose (GE Healthcare) coupled with
GST-PHF8 or GST-ZNF711. Antibody specificity was tested and confirmed
by immunoblotting and immunoprecipitation.
Demethylation Assay
For the generation of recombinant proteins, please see the Supplemental
Experimental Procedures. Calf thymus histones (Sigma Aldrich) or synthetic
histone H3 peptides (ARTKQTARKSTGGKAPRKQLATKAARKSAPATGGVKK
PHR-YC-Ttds-K-Biotin; JPT, Germany) mono-, di-, or trimethylated at the
K9 or K27 position were incubated with purified Flag-His-PHF8, GST-PHF8
(amino acids 1–548) or Flag-His-cePHF8 for 60 min at 37C in demethylation
buffer (50 mM HEPES-KOH [pH 7.7], 250 mM NaCl, 1 mM MgCl2, 1 mM a-ke-
toglutarate, 40 mM FeSO4, and 2 mM ascorbic acid). Reaction mixtures were
analyzed by either western blotting using specific antibodies (as listed in the
Supplemental Experimental Procedures) or mass spectrometry. For mass
spectrometry analysis, four micrograms of recombinant GST-PHF8 was incu-
bated with 2.5 mg either H3K9me3, H3K9me2, H3K9me1, or H3K27me3
peptide in demethylation buffer in a final volume of 90 ml for 30 min at 37C.
Reaction mixtures were analyzed as previously described (Christensen
et al., 2007).
ChIP Assays
Chromatin immunoprecipitation assays (ChIP) were performed and analyzed
as previously described (Bracken et al., 2006). A detailed protocol for ChIP-
seq analysis and antibodies used for ChIP are included in the Supplemental
Experimental Procedures.
ACCESSION NUMBERS
The genome-wide mapping data of H3K4me3, PHF8, and ZNF711 for
SH-5YSY cells reported in the paper are available at the Gene Expression, PHF8, and H3K4me3 in human neuroblastoma SH-SY5Y cells.
2 for ZNF711 and PHF8 obtained from ChIP-seq analysis; the chromosomal
icate the number of sequenced reads.
-SY5Y cells using antibodies against ZNF711, PHF8, H3K4me3, H3K9me2, and
f input.
s after shRNA-mediated ZNF711 knockdown using antibodies against ZNF711,
F711 and PHF8 knockdown in HEK293 cells using real-time RT-qPCR.
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